Human Recombinant Sclerostin, STEMCELL Technologies (CAT#: STEM-CT-0767-ZJF)

Use sclerostin to alter bone remodeling homeostasis, where it inhibits bone formation in vivo and in vitro, likely through Wnt/β-catenin signaling cascades (Ellies et al.; Lin et al.). Sclerostin is a member of the cerberus/DAN family of glycoproteins whose members share a C-terminal cysteine-knot-like (CTCK) domain. Highly expressed in bone and cartilage, as well as in kidney, and liver tissues (Weivoda et al.), this osteoclast-derived BMP antagonist binds BMP6 and BMP7 with high affinity, and binds BMP2 and BMP4 with a lower affinity (Kusu et al.). Mutations in the SOST gene have been associated with sclerosteosis (Brunkow et al.), van Buchem disease (Staehling-Hampton et al.), and bone dysplasia disorders, characterized by increased bone density. This protein product contains a His-residue tag at the carboxyl end of the polypeptide chain. For consistency and reproducibility across your applications, sclerostin from STEMCELL comes lyophilized with ≥ 87% purity, and endotoxin levels are verified to be ≤ 1.0 EU/μg protein.

Subtype: Cytokines
Alternatives Names: CDD, DAND6, SOST, SOST1, VBCH
Species: Human
Area of Interest: Metabolism
Purity: ≥ 87%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human Recombinant ANGPTL2, STEMCELL Technologies
Human Recombinant IL-37, STEMCELL Technologies
Human Recombinant Hepassocin, STEMCELL Technologies
Human Recombinant C-Reactive Protein, STEMCELL Technologies